-
Request a Free Sample to learn more about this report
HOME INFUSION THERAPY DEVICES MARKET REPORT OVERVIEW
The future of patient-centric healthcare is here! The home infusion therapy devices market is set to grow at a CAGR of 3.94%, reaching US$ 2817.34 million by 2032. In 2023, the market was valued at US$ 1914 million.
Home infusion therapy devices deliver medication and nutrient fluids into the body and improve patient comfort and treatment. These devices include IV push where a patient’s drugs are delivered through an IV catheter at a fast rate and gravity which involves fluids dripping from an IV bag. Infusion balls which are also referred to as elastomeric devices, offer steady medicine administration through an elastomeric balloon. Another advantage is related to the ability to be mobile during a continuous infusion through the usage of ambulatory pumps, also known as CADDs. Stationary home infusion pumps are somewhat less portable as compared to other options, yet they are capable of delivering high rates of infusion required for certain treatments. These devices enable efficient delivery of care at homes without conventional clinical settings.
Home infusion therapy is handled mainly by home infusion providers who are closed-door speciality pharmacies that meet high licensing standards of the state and the requirements for the preparation of sterile products according to USP <797>. This mode of therapy has the advantage of being cheaper throughout the overall population because hospitalizations are reduced and patients can get the treatments they require in the comfort of their home environments. They can get back to work and other normal daily activities, hence improving the quality of life since they recover fully from diseases. The fact that home infusion therapy is as convenient as it is makes the option more significant in the current healthcare setting as a recognized means of managing long-term or chronic diseases.
COVID-19 Impact: Pandemic has accelerated the trend toward home-based healthcare helping propel the market
The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
The pandemic has increased the rate at which home-based healthcare is adopted because people want to avoid frequent hospital visits. This trend has indeed positively contributed to the need for mobile, convenient and easy-to-use home infusion therapy devices. These devices allow patients to receive their required therapies such as medication and nutrition fluids in the comfort of their homes. The shift towards home care has driven improvements in infusion technology where devices are often made available and easier to operate. Hence, patients can receive their check-ups and other necessary care while avoiding the definite hazards of regular hospital visits, making for a safer and more effective approach to care provision.
LATEST TRENDS
"Technological development of new devices with better monitoring capacity to boost the market"
Technology is progressively continuing to change home infusion therapy through the development of new devices that are easier to use, mobile and with better monitoring tools. These innovations also give the patient a way of administering their treatments on their own at home. Current infusion pumps come with user-friendly interfaces and often self-programmed functions and therefore do not present a steep learning curve or a high chance of error. Incorporated portability ensures that patients can continue with their everyday activities after getting access to their needed equipment. Also, remote patient monitoring facilities such as wireless telemetry and real-time data acquisition enhance an effective manner of overseeing patient therapy to allow timely interventional action. Each of these advancements improves the accessibility, convenience and safety of home infusion therapy, thus positively affecting patient outcomes and quality of life.
-
Request a Free Sample to learn more about this report
HOME INFUSION THERAPY DEVICES MARKET SEGMENTATION
By Type
Based on type the global market can be categorized into Disposable Elastomeric Pumps, Insulin Pumps, PCA Pumps, Electronic Ambulatory Pumps and Infusion System Pumps Accessories.
- Disposable elastomeric pumps: These devices are designed for single use and assure sterility while minimizing cross-contamination. Easy to operate, they are suitable for patients with poor technical levels. The pumps are more cost-effective because they help reduce the overall infusion therapy costs and have no maintenance or cleaning needs, hence streamlining the process. Single-use design ensures higher patient safety by limiting infection risks and providing a sterile infusion environment.
- Insulin Pumps: They ensure the proper delivery of the optimum amount of insulin a patient needs to obtain good glucose control, reducing their risk of hypoglycemia. They provide flexibility and ease of management for patients with diabetes so they can regain some of their independence and live life as actively as possible because fewer injections are required. With additional advanced monitoring facilities to track changes in glucose levels and have treatment modified accordingly, patient engagement is increased with empowerment over managing their diabetes.
- PCA Pumps: PCA pumps provide the patient with control over pain management, thereby increasing self-autonomy and decreasing anxiety. It facilitates medication administration in the proper dosage for optimal pain control while avoiding many side effects. The amounts it dispenses are limited in the medication to avoid overdose. The several ways that PCA pumps improve patient satisfaction include reduced repeated hospital visits, advanced pain management and a greatly improved quality of life.
- Electronic Ambulatory Pumps: They are portable and as such, they allow patients to get their infusion therapy while on the go. They have high-level monitoring of treatment progress and the possibility for adjustment of infusion rates in different conditions. The pumps reduce accidental complications by providing a safe and effective infusion process. Better therapeutic efficacy leads to improved outcomes for patients.
- Infusion System Pumps Accessories: Infusion system pump accessories can be personalized at various levels to allow healthcare professionals to treat the needs of individual patients. Features such as alarms and alerts make this infusion process much safer, more secure and more secure for the patients. These accessories smoothen out procedures, thus reducing errors and increasing efficiency, while also improving patient comfort through ergonomic design and quiet operation. Advanced integration with other devices further enhances patient outcomes.
By Downstream Industry
Based on downstream industry the global market can be categorized into Enteral Nutrition, Parenteral Nutrition, Chemotherapy, Antibiotic Administration and Others.
- Enteral Nutrition: The growing cases of chronic diseases, such as gastrointestinal disorders and cases of cancers are also continuing to raise demand for enteral nutrition. It can be used at home, reducing the number of visits to hospitals, increasing comfort to the patient and ensuring more safety from exposure to new nosocomial infections. Advanced technology in the form of infusion pumps and feeding tubes ensures appropriate dosing, reducing complications and hence improving patient safety. Home-based enteral nutrition helps lower healthcare expenditure and is cost-effective while improving patients' outcomes generally by providing convenience, comfort and improved health quality.
- Parenteral Nutrition: Chronic diseases such as cancer and gastrointestinal disorders are increasing hence, the demanding cases of parenteral nutrition. Advanced infusion pumps offer effective dosing and thus reduce the possibility of leading to complications, hence guaranteeing the safety of patients. It increases convenience and allows them to manage their conditions effectively, thus improving the quality of their lives. Home-based management is cost-effective as compared to care in a hospital by reducing expenditure on healthcare. It also increases patient safety by eliminating risks associated with oral nutrition.
- Chemotherapy: With the surge in cases of cancer, there is a growing need for chemotherapy in most cases, which would be conducted in the comfort of one's own home. Advanced infusion pumps will guarantee the right dosage with few complications, thereby improving safety measures. Home-based chemotherapy improves the quality of life since patients will manage their condition from home away from the hospital. It is cost-effective compared to care in a hospital by reducing costs in health care with improved patient outcomes through safety measures.
- Antibiotic Administration: The rising number of infections, such as pneumonia and urinary infections, would increase the requirement towards antibiotic administration. Today, as advanced infusion pumps are developed that could facilitate correct dosing and reduce complications, patients could administer this at their convenience and hence improve their quality of life. Home antibiotic therapy is less expensive as compared to hospitalization and thus reduces health expenditure. This will also enhance patient safety because all the risks associated with oral antibiotics are reduced.
- Others: The increase in demand for speciality therapies, such as hydration and pain management, is also speeding up the growth of home infusion therapy. Advanced pumps can measure correct dosages and reduce as many complications as possible to enable maximum benefit to the patient by managing his or her condition at home and hence, his or her quality of life. Home-based administration is cost-effective compared to hospital care, lowering healthcare expenses while improving patient outcomes and safety by reducing risks associated with oral medications.
DRIVING FACTORS
"Rising incidence of chronic diseases directly impacts the market positively"
The rising incidence of chronic diseases such as diabetes, cancer and congestive heart failure has propelled the global Home Infusion Therapy Devices Market growth. Such conditions often call for chronic care and medication and home infusion therapy is often preferred by patients at that time. Some of the devices used in home infusion therapy entail complex infusion pumps and elastomeric devices for the administration of medications, fluids and nutritional support to patients within their homes. This is also a way in which the patient will benefit, they will not have to visit the hospital frequently to receive their checkups and therefore there will be improved compliance with treatment regimens. These devices enable the provision of consistent and regulated therapy that leads to enhancement of the quality of life as well as greater positive results for patients. They also enable the healthcare providers to be able to track as well as modify the patients’ treatments whenever needed, hence making sure the patients receive individualized treatment which keeps the overall healthcare costs low especially due to the elongated hospital stays caused by chronic illnesses.
"Increase of government policies and insurance coverage to increase the size of the market"
Reimbursement policies from government agencies, as well as insurance service providers, are continuously aligning with the cost benefits of home infusion therapy for patients. Such policies recognize that home care has several advantages over hospital care, lower frequency of hospitalizations, increased patient comfort and lesser healthcare costs in the long run. Several government insurance schemes have extended the range of services they offer home infusion and have also provided reimbursement for equipment or supplies that may be needed. Also, private insurance firms are coming to realize the benefits that home infusion therapy can offer in terms of controlling healthcare costs and at the same time, delivering superior care for many chronic illnesses. They allow users to benefit from specified services including the infusion pump, medications, as well as home health nursing services, for instance, availing specialized treatment in the home environment with additional charges compared to hospitalization. With changes in the reimbursement policies and policies expanding across the country, home infusion therapy is now affordable to patients and convenient as compared to conventional healthcare facilities.
RESTRAINING FACTORS
"Risks associated with the administration of medications to hinder the market"
Home infusion therapy devices also possess inherent medication administration risks, which may threaten market development. Infections are a major risk even though invasive procedures involve the introduction of foreign bodies into the body since this increases the chances of infection especially where sterile measures are ignored. Another source of pressure-related risk is air embolisms that can occur with new infusion lines being connected or during the process of removal and could cause severe cardiovascular issues. There is also the issue of medication errors, such as wrong dosages or administration of different medications than what was prescribed, which can compromise patient safety and effective treatment. These risks reaffirm the necessity for strict guidelines in the use of such devices, adequate education of healthcare personnel and patients, and effective surveillance to identify and address potentially undesirable outcomes quickly. Meeting these challenges implies further progress in technologies and devices used in home infusion therapy, compliance with security standards and extensive training for all concerned in shifting practices to safer levels to help initiate market growth due to improved patient trust and conformance to regulations.
-
Request a Free Sample to learn more about this report
HOME INFUSION THERAPY DEVICES MARKET REGIONAL INSIGHTS
The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
"North America has a well-developed healthcare infrastructure which propels the market"
North America has a well-developed healthcare system that will enable the adoption and implementation of services such as home infusion therapy. The region has proper regulatory measures and sounds healthcare systems, which enable it to propel the uptake and integration of advanced medical solutions quickly. Home infusion therapy, through which patients can receive highly specialized treatments within the comfort of their own homes, complements the North American market’s focus on patient-centred care initiatives and reduces overall healthcare costs. The increased involvement of specialized home infusion providers and closed-door pharmacies guarantees compliance with essential safety and quality standards imposed by USP <797> for sterile compounding. Also, North American-based healthcare providers are well conversant with the use of IV pending and other home therapy gadgets making patients safer and treatment more effective. In conclusion, the region’s endowments to having an advanced healthcare system provide a favourable condition that can enhance the expansion and development of the global home infusion therapy device market share as an improved substitute to a hospital-based treatment.
KEY INDUSTRY PLAYERS
"Leveraging technological advancements has become a strategic agenda for key industry players to for market expansion"
Key industry players in the home infusion therapy industry have embraced product differentiation as the market evolves to meet healthcare demands. Such approaches are leading to the development of enhanced devices that come outfitted with intelligent connectivity capabilities which allow for the monitoring and even controlling of treatments from a distance. Such innovations also benefit patients by again increasing their convenience, but they also provide caregivers with prompt information and possible alarms to guarantee better results in treatment. There have also been advancements in safety measures with devices comprising built-in fail-safe systems to eliminate dangers during the administration of the solutions. However, these improvements are made to simplify the administration process, dose accuracy and to minimize errors. In optimizing new technology features such as smart connectivity and remote monitoring, companies are not only improving the quality and safety of home infusion therapy but also extending its reach and utilization across healthcare systems around the world. This desire for change emphasizes the potential for enhancing the quality of client care and treatment outcomes in home environments.
LIST OF MARKET PLAYERS PROFILED
- CareFusion (U.S.)
- Smiths Medical (U.S.)
- JMS (U.S.)
- ICU Medical (U.S.)
- Fresenius Kabi (Germany)
- Braun Melsungen (Germany)
- Caesarea Medical Electronics (Israel)
- Terumo (Japan)
INDUSTRIAL DEVELOPMENT
March 2024: In November 2024, Fresenius Kabi completed the divestment of its Halden, Norway plant to the Prange Group. This move aligns with Fresenius Kabi’s Vision 2026 strategy. The Prange Group, known for its B2B pharmaceutical expertise, acquired the plant, equipment, and employees. Fresenius Kabi’s Norwegian Market Unit remains unaffected, continuing its commitment to the Norwegian market since 1999.
REPORT COVERAGE
The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.
The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 1914 Million Million in 2023 |
Market Size Value By |
US$ 2817.34 Million Million by 2032 |
Growth Rate |
CAGR of 3.94% from 2023 to 2032 |
Forecast Period |
2032 |
Base Year |
2023 |
Historical Data Available |
2019-2022 |
Regional Scope |
Global |
Segments Covered |
Type and Application |
-
What value is the Home Infusion Therapy Devices Market expected to touch by 2032?
The global Home Infusion Therapy Devices Market is expected to reach USD 2.81 billion by 2032.
-
What CAGR is the Home Infusion Therapy Devices Market expected to exhibit by 2032?
The Home Infusion Therapy Devices Market is expected to exhibit a CAGR of 3.94% by 2032.
-
Which are the driving factors of the Home Infusion Therapy Devices Market?
Rising incidence of chronic diseases, and increase of government policies and insurance coverage are some of the driving factors of the market.
-
What are the key Home Infusion Therapy Devices Market segments?
The key market segmentation that you should be aware of, which include, Based on type the Home Infusion Therapy Devices Market is classified as Disposable Elastomeric Pumps, Insulin Pumps, PCA Pumps, Electronic Ambulatory Pumps and Infusion System Pumps Accessories. Based on downstream industry the Home Infusion Therapy Devices Market is classified as Enteral Nutrition, Parenteral Nutrition, Chemotherapy, Antibiotic Administration and Others.